Ontario Industry Updates

Quick Biotechnology Survey on Employee Perception of the Workplace

Biotechnology Focus, in collaboration with Stratford Managers Corporation, wants to learn more about employee perception of their workplace.

Please complete the survey in its entirety before September 22nd. The responses will be included in in a sector report that will be featured in the October/November issue of Biotechnology Focus.

To start the Survey click here

Seed Funding Available: Weston Brain Institute Launches Rapid Response - Canada 2018 Program for Parkinson’s & Related Diseases

Program Overview

Seed funding for novel, high-risk, high-reward translational research to accelerate the development of safe and effective treatments for neurodegenerative diseases of aging. Funding up to $200,000 over up to 18 months

Letter of Intent Deadline: December 4, 2017 at 2pm EST

Program Information Session: October 10, 2017 at 1pm EDT (Register here)

Application Form

Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US $290 Million

Therapure Biopharma Inc. today announced that a joint venture between 3SBio Inc., a leading global biotechnology company, and CPE Funds has entered into an agreement to acquire Therapure’s contract development and manufacturing (CDMO) business and certain rights to plasma products and technology for the Chinese market for US$290 million, subject to certain adjustments.

Call for Applications - Industry Innovation Partnership Program, Up to $3M Available

The Centre for Aging + Brain Health Innovation (CABHI) announced today the second round of funding available through its Industry Innovation Partnership Program (I2P2). This program is designed to enable successful applicant companies worldwide to accelerate the evaluation and adoption of their innovative products and services that can help to address the needs of aging adults. In total, up to $3 million CAD in funding will be available for solution testing and validation. 

Reliq Health Announces Go-Live with 30,000 Patient Primary Care Group in Texas

VANCOUVER, BC, August 17, 2017. Reliq Health Technologies Inc. a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community‐Based Healthcare, is pleased to announce the golive of remote patient monitoring, care coordination and telemedicine platform with their Rio Grande Valley Health Alliance in McAllen, Texas.

BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership

TORONTO and CAMBRIDGE, Mass., Aug. 17, 2017. BlueRock Therapeutics, which is developing cell-based therapies designed to alter the course of degenerative disease, today announces the expansion of the company's presence in Toronto with a research, development and manufacturing site in the MaRS Discovery District.